Comparison of design characteristics and toxicant emissions from Vuse Solo and Alto electronic nicotine delivery systems

Author:

Talih SohaORCID,Karaoghlanian NaregORCID,Salman Rola,Fallah Sacha,Helal Alissa,El-Hage Rachel,Saliba NajatORCID,Breland AlisonORCID,Eissenberg ThomasORCID,Shihadeh AlanORCID

Abstract

IntroductionVuse Solo is the first electronic nicotine delivery system (ENDS) authorised by the US Food and Drug Administration for marketing in the USA. Salient features of the Vuse Solo product such as nicotine form, draw resistance, power regulation and electrical characteristics have not been reported previously, and few studies have examined the nicotine and other toxicant emissions of this product. We investigated the design characteristics and toxicant emissions of the Solo as well as Alto, another Vuse product with a greater market share than Solo.MethodsTotal/freebase nicotine, propylene glycol to vegetable glycerin ratio, carbonyl compounds (CC) and reactive oxygen species (ROS) were quantified by gas chromatography, high-performance liquid chromatography and fluorescence from aerosol emissions generated in 15 puffs of 4 s duration. The electric power control system was also analysed.ResultsThe average power delivered was 2.1 W and 3.9 W for Solo and Alto; neither system was temperature-controlled. Vuse Solo and Alto, respectively, emitted nicotine at a rate of 38 µg/s and 115 µg/s, predominantly in the protonated form (>90%). Alto’s ROS yield was similar to a combustible cigarette and one order of magnitude greater than that of Solo. Total carbonyls from both products were two orders of magnitude lower than combustible cigarettes.ConclusionVuse Solo is an above-Ohm ENDS that emits approximately one-third the nicotine flux of a Marlboro Red cigarette (129 µg/s) and considerably lower CC and ROS yields than a combustible cigarette. With its higher power, the nicotine flux and ROS yield from Alto are similar to Marlboro Red levels; Alto may thus present greater abuse liability than the lower sales-volume Solo.

Funder

National Institute on Drug Abuse of the National Institutes of Health

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health (social science)

Reference24 articles.

1. FDA . FDA permits marketing of E-cigarette products, marking first authorization of its kind by the agency. Available: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-e-cigarette-products-marking-first-authorization-its-kind-agency [Accessed 19 Apr 2022].

2. US-FDA . Technical project lead {TPL} review of pmtas. 2021.

3. businesswire . Bluehole publishes an industry comment on vuse overtaking Juul and becoming the U.S vaping market champion again. Available: https://www.businesswire.com/news/home/20220512005478/en/ [Accessed 24 Aug 2022].

4. truthinitiative . Key concerns about FDA’s first e-cigarette authorization for vuse solo. 2021. Available: https://truthinitiative.org/research-resources/emerging-tobacco-products/key-concerns-about-fdas-first-e-cigarette#:~:text=Vuse%20Alto%2C%20the%20brand%20most,Alto%20version%2C%20is%20the%20no.(Published [Accessed 19 Apr 2022].

5. Emissions of free radicals, carbonyls, and nicotine from the NIDA standardized research electronic cigarette and comparison to similar commercial devices;Bitzer;Chem Res Toxicol,2019

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3